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Osteoarthritis is the most common form of arthritis and is frequently diagnosed and man-
aged in primary care; it is characterized by loss of articular hyaline cartilage, which is a
unique connective tissue that physiologically lacks blood vessels. Articular cartilage survives
in  a microenvironment devoid of oxygen, which is regulated by hypoxia inducible factor (HIF-
1).  HIF-1 is considered the main transcriptional regulator of cellular and developmental
response to hypoxia. To date, the relevance of HIF-1 in the assessment of cartilage has
increased since its participation is essential in the homeostasis of this tissue. Taking into
account the new emerging insights of HIF-1 in the scientiﬁc literature in the last years, we
focused the present review on the potential role of HIF-1 signaling pathway in osteoarthri-
tis  development, especially in how some genetic factors may inﬂuence the maintenance or
breakdown of articular cartilage.
© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Papel  da  via  de  sinalizac¸ão  do  HIF-1  na  osteoartrite:  revisão  sistemática
alavras-chave:
r  e  s  u  m  o
A osteoartrite (OA) é a forma mais comum de artrite e frequentemente é diagnosticada e
ator induzível por hipóxia 1- gerenciada na atenc¸ão primária; é caracterizada por perda da cartilagem articular hialina,
ia de sinalizac¸ão do HIF-1Please cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.008
olimorﬁsmos genéticos
steoartrite
um  tecido conjuntivo único que ﬁsiologicamente carece de vasos sanguíneos. A cartilagem
articular sobrevive em um microambiente desprovido de oxigênio, que é regulado pelo
fator induzível por hipóxia-1 (HIF-1). O HIF-1 é considerado o principal regulador tran-
scricional da resposta celular e de desenvolvimento à hipóxia. Na atualidade, a relevância
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do HIF-1 na avaliac¸ão da cartilagem tem aumentado, já que a sua participac¸ão é essencial
na  homeostase desse tecido. Considerando as novas perspectivas emergentes do HIF-1 na
literatura cientíﬁca nos últimos anos, foca-se a presente revisão no potencial papel da via
de  sinalizac¸ão do HIF-1 no desenvolvimento da OA, especialmente no modo como alguns
fatores genéticos podem inﬂuenciar na manutenc¸ão ou ruptura da cartilagem articular.
©  2016 Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CCIntroduction
Osteoarthritis (OA) is a common chronic condition affecting
millions of people worldwide and is a considerable cause of
disability.1 It is the most common rheumatic disease, every age
can be affected but prevalence increases dramatically with age
with a greater incidence in subjects between 40 and 50 years
old.2
The joints involved are characterized by a breakdown
and loss of articular cartilage that leads to a decrease in
the joint space and friction between the bones causing
swelling, chronic pain, functional impairment, deformity and
disability.3–6
To date, the hypoxia inducible factor-1 alpha (HIF-1)  has
increased its relevance in the assessment of cartilage since its
participation is essential in the homeostasis of this tissue.7
Articular cartilage is a hypoxic tissue in which HIF-1  is of
pivotal importance for survival and growth of chondrocytes
during cartilage development as well as energy generation and
matrix synthesis of chondrocytes in both healthy and patho-
logical conditions.8,9 By using microarrays, it was also shown
that HIF-1  is expressed in human fetal chondrocytes, which
means that this transcription factor is essential for develop-
ment and maintenance of cartilage.10
The viability of chondrocytes is compromised by several
phenomena such as oxidative stress, inﬂammatory mediators,
biochemical injury and hypoxic conditions. The avascularity
of cartilage tissue has allowed establishing well conserved
mechanisms where the chondrocytes can survive under such
conditions. It is note, that under healthy conditions, oxygen
concentration in articular cartilage varies from 0.5 to 10%
(∼4–70 mm Hg, respectively).11,12 When oxygen concentration
decreases and environment turns increasingly hypoxic, HIF-
1 plays a critical role to maintain homeostasis, through
induction the expression of a variety of genes encoding pro-
teins to increase the availability of oxygen and nutrients to
homeostatic levels.8,13
Taking into account of these pieces of information and the
recent growing interest in HIF-1 in rheumatic diseases,14,15
we  focused the present review on the potential role of HIF-1
in OA, especially in as some genetic factors may inﬂuence in
the maintenance or breakdown of articular cartilage.
Methods
Literature  review  criteria  and  search  strategyPlease cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
All relevant literature in the ﬁeld of HIF-1 and OA, published
in the last 15 years was reviewed. The search included originalBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
articles concerning humans and/or animal models published
between January 2000 and December 2015. To identify all avail-
able studies, a detailed search pertaining to HIF-1 and OA was
conducted according to PRISMA (Preferred Reporting Items
for Systematic reviews and Meta-Analyses) guidelines.16 A
systematic search was performed in the electronic database
(PubMed) using the following Mesh search terms in all pos-
sible combinations: “HIF-1”  or “osteoarthritis” or “articular
cartilage” or “HIF-1 polymorphisms” or “HIF-1 signaling
pathway” or “hypoxia” or “rheumatic diseases”, and the com-
bined phrases in order to obtain all genetic studies on the
relationship of genetic polymorphisms of HIF-1 signaling
pathway associated with OA. In addition, the reference lists
of all retrieved articles were manually reviewed. Two inde-
pendent authors (JFT and GAMN) analyzed each article and
performed the data extraction independently. Discrepancies
were resolved by consensus.
Inclusion  and  exclusion  criteria
We excluded from this review the following types of publica-
tions: articles not published in English, case reports, clinical
trials, and letters to the editor that were purely commen-
tary. Search results were screened to avoid duplicates. Titles,
abstracts, and full reports of articles identiﬁed were systemat-
ically screened with regard to inclusion and exclusion criteria.
Results
To date, it has compiled important information about the role
of HIF-1 in rheumatic diseases. Approximately 5599 publi-
cations were identiﬁed in PubMed database between January
2000 and December 2015. The results of the search strategy
are illustrated in Fig. 1.
General  concepts  of  OA  genesis  and  genetics
In the last years, the knowledge of OA has grown exponen-
tially; however, there are still gaps that have not been possible
to address. Currently, cases of OA in very young people are
most frequently reported, which gradually induces to change
the concept that OA is a disease of elders only. Also, there
are very heterogeneous intermediate phenotypes deﬁning the
different degrees of severity of OA, since slight crackles of
joint, until total loss of articular cartilage. This process is com-
plex, but it is thought that the interaction of biomechanical
stress, proinﬂammatory cytokines, metabolic, environmental, Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
and mainly genetic factors, are the orchestrators that promote
the disruption of cartilage homeostasis and initiation of the
catabolic pathway.6,17–22
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Search terms entered in PubMed database : “HIF-1α”or “osteoarthritis” or “articular cartilage”
or “HIF-1α polymorphisms” or “HIF-1α signaling pathway” or “hypoxia” or “rheumatic diseases”,
and the combined phrases in order to obtain all genetic studies on the relationship of
genetic polymorphisms of signaling pathway of HIF-1α associated
with osteoarthritis.
5599 studies identified in
database search
383 potential eligible studies
identified
76 full-tex articles assessed
for elegibility
5214 studies excluded: not published in english,
case reports, clinical trials, letters to the editor that
were purely commentary, published before 2000.
309 studies excluded not related to given topic.
Fig. 1 – Representation of the search strategy.
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lAlthough the pathophysiology of OA is not fully charac-
erized, several candidate genes have been reported to be
ssociated with OA susceptibility. Fernández-Moreno et al.
etermined that despite the multifactorial nature of OA, it
ot follows the Mendelian inheritance patterns, most likely
y the alterations of gene interactions.20 They analyzed differ-
nt genes located on different chromosomes, and the results
evealed the complexity of this ﬁeld. Table 1 shows some genes
nd their relationship with the different phenotypes of OA
escribed in this study.
Meulenbelt published a study aimed to determine which
ignaling pathways were most important to the development
f OA.6 The most common pathways or genes were the 7q22
ocus containing multiple potential genes, the growth differ-
ntiation factor5 (GDF5) gene, frizzled related protein (FRZB)
ene, the deiodinase iodothyronine, type II (DIO2) gene and
he SMAD3 gene.
The genetic bases in OA can further reﬁne the under-
tanding of the genotype–phenotype relationship, through the
resence of single nucleotide polymorphisms (SNP). A genetic
olymorphism can be a pivot between a mechanism of resis-
ance or susceptibility in a disease. Genetic polymorphisms
hat affecting a coding or regulatory sequence and producePlease cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
ajor changes in protein structure or mechanism of regu-
ation of expression, can result in different phenotypes.23,24
n Table 2 we  show some SNPs with phenotypes well estab-
ished.Function  and  structure  of  articular  cartilage
Articular cartilage is a highly specialized tissue of joints; its
principal function is to provide a smooth, lubricated surface
for articulation and to facilitate the transmission of loads with
a low frictional coefﬁcient. Injury to articular cartilage is rec-
ognized as a cause of signiﬁcant musculoskeletal morbidity.
The unique and complex structure of articular cartilage makes
treatment, and repair or restoration of its defects challeng-
ing for the patient, the surgeon, and the physical therapist.
The preservation of articular cartilage is highly dependent on
maintaining its organized architecture.40
Articular cartilage is the primary target tissue in the degen-
erative process; there are very particular characteristics that
make it different from the others, protruding their lack of
capillary network. Articular cartilage consists of extracellu-
lar matrix (ECM), proteoglycans, chondrocyte, collagen and
water; receives its nutrients and oxygen supply by diffusion
from the dynamic ﬂow of synovial ﬂuid and subchondral bone.
The regulation of metabolism of articular cartilage involves
a vast network of signaling pathways that, in the case of
OA, the delicate balance between synthesis and degradation
of ECM, is strongly affected. Thus, the osteoarthritic process Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
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begins with a decreased resistance to extrinsic stress of chon-
drocytes, along with changes in the activity of proliferation,
energy metabolism and response to growth factors.41–46 The
breakdown of cartilage during the OA pathogenesis is not
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Table 1 – Genes associated with the development of OA.
Gene Chromosome Phenotypic
manifestation
COL2A1,
COL11A1,
COL11A2
1, 6, 12 Early onset OA
COL9A1 6 Early onset of knee
OA
MATN3 2 Early onset of hand
and knee OA
COMP 19 Early onset of hip OA
hip
COL1A1 17 Reduction of hip OA
in women
BMP2 20 Reduction of knee
OA in women
TGFB1 19 OA
FRZB, IL4R 2, 16 Hip OA in women
IL1, ASPN, TIMP3 2, 9, 22 Hip and knee OA
IL6 7 Hip OA
AGC1 15 Hand OA
VDR 12 Arthritis in several
joints
ERA 6 OA in women
ADAM12, LRCH1,
TNA
3, 10, 13 Knee OA
CILP 15 Knee OA in men
CALM1 14 Hip OA in Japanese
population
IGF-1 12 Increased risk of OA
IL17 6 Susceptibility to
develop OATaken and modiﬁed from Fernández-Moreno et al.20
only related to the loss of ECM but also chondrocytes death.
Chondrocyte death by apoptosis, necrosis, chondroptosis, or
combination of these processes has been implicated in the
pathogenesis of OA.47Please cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
The  HIF-1 system
HIF-1  is a transcriptional factor encoded by the HIF1A gene
located within chromosome 14q21-24 and is formed by 15
Table 2 – Single nucleotide polymorphisms (SNP) associated wi
Gene/dbSNP rs Id Phenot
WISP1 rs2929970 Susceptibility to spinal OA i
RAGE rs2070600 Susceptibility to knee OA 
DVWA rs7639618 Susceptibility to knee OA 
ACE rs4343, rs4362 Susceptibility to knee OA 
MATN3 rs8176070 Susceptibility to OA 
DIO2 rs225014 Susceptibility to OA 
ADAMTS14 rs4747096 knee OA in woman (Thai po
ADAM12 rs1871054 Increased risk of OA 
HIF1A rs11549465 Protective role in the loss of
IL6 rs1800796 Protective factor for hip and
IL16 rs11556218, rs4072111, rs4778889 Decreased knee OA risk 
GDF5 rs143383 Protective factor for knee O 1 6;x  x x(x x):xxx–xxx
exons; HIF-1 consists of 826 amino acids and it has a molec-
ular weight of 120 kDa.48 HIF-1 is a heterodimer of two
chains, alpha chain (regulated by oxygen) and beta chain,
both arranged in a double helix (basic helix–loop–helix, bHLH).
There are two nuclear localization signal (NLS), but only that
found in the C-terminal position it is responsible for the accu-
mulation of HIF-1 in the nucleus. In the N-terminal region,
is located the bHLH and PER-ARNT-SIM A (PAS A) domains,
necessary for dimerization and DNA binding through hypoxia
response elements (HRE). Finally, the active site of this pro-
tein is an oxygen dependent degradation domain (ODDD) that
functions as an oxygen sensor (Fig. 2).49–51
Under normoxia and in the presence of Fe2+ and 2-
oxoglutarate, the speciﬁc proline residues 402 and 564 are
hydroxylated on ODDD domain by prolyl-hydroxylases (PHDs)
oxygen dependents, to form a complex with the factor of
von Hippel-Lindau (VHL); in turn, this complex binds to ubiq-
uitin (Ub) and it subsequently degraded in the proteasome
(Fig. 3).
An external stimulus cellular, as a growth factor that
binds to its receptor tyrosine kinase, triggers a cas-
cade of signaling pathways within the cell. For example,
vascular endothelial growth factor (VEGF) activates the
phosphatidylinositol-3-kinase (PI3K) and mitogen-activated
protein kinase (MAPK) pathways (ERK1 and ERK2).52 PI3K acti-
vates the serine/threonine kinase (AKT), and AKT activates the
FKBP12 rapamycin-associated protein, mTOR, RAFT (FRAP),
which induces the expression of HIF-1.
Under conditions of reduced oxygen (hypoxia), PHDs activ-
ity decreases, which stabilizes HIF-1 and accumulates in the
cytoplasm to be phosphorylated by MAPK.53–55 Once phos-
phorylated, HIF-1 it translocates to the nucleus and binds
to HIF-1  subunit (also known as aryl hydrocarbon nuclear
translocator, ARNT) to form the [HIF-1/HIF-1]  complex. This
complex through the HRE, binds to speciﬁc DNA sequences
5′TAGCGTGH3′ present in promoter regions of genes for sub-
sequent expression.47,55,56
Some of these target genes include nitric oxide synthase
2 (NOS2), vascular endothelial growth factor (VEGF), eryth- Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
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ropoietin (EPO), some glucose transporters (GLUT1, GLUT3),
Insulin-like growth factor type 2 (IGF2), which potentially acts
in order to maintain the chondroprotective functions chal-
lenged by the detrimental conditions occurring in the OA
th OA processes.
ype First author [Reference]
n woman Urano et al.25
Han et al.26
Zhang et al.27
Qing et al.28
Gu et al.29
Meulenbelt et al. 30
pulation) Poonpet et al.31
Wang et al.32; Kerna et al.33
 articular cartilage Fernández et al.34
 knee OA in the elderly Fernandes et al.35
Luo et al.36; Liu et al.37
A Pan et al.38; Tawonsawatruk et al.39
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Fig. 2 – Structure of hypoxia inducible factor 1- (HIF-1). The NH2-terminal of HIF-1  and HIF-1  consists of bHLH (basic
helix–loop–helix) and PAS (Per-ARNT-Sim homology) domains that are required for heterodimerization and DNA binding.
The COOH-terminal of HIF-1  (residues 531–826) contains two transactivation domains (TADs). The short half-life of HIF-1
under nonhypoxic and posthypoxic conditions is due to rapid ubiquitination and proteasomal degradation. HIF-1  residues
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p00–600, this region was designated the oxygen-dependent
oint environment (Fig. 4).8,54–59 This relationship among dif-
erent genes renders the close relation of HIF-1 with several
athologies.60–64
enetic  polymorphisms  in  the  HIF-1 system
nd  their  importance  in  OAPlease cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
o try to explain simply the interaction of genetic polymor-
hisms associated with HIF-1 with importance in OA, we
ivided this system into three stages: (1) genes that activate
Normo
Ubiqui
Hidroxilation
O2
PHD
OH
OH
HIF-1α HIVHL
VHL
OH
OH
ig. 3 – HIF-1  activity under normoxic conditions. Under normo
DDD domain are hydroxylated by oxygen dependent prolyl-hyd
ith the von Hippel-Lindau (VHL) factor; which in turn, binds to 
roteasome.adation domain (ODDD).
HIF-1; (2) proteins that directly interact with HIF-1; and (3)
genes driven by HIF-1.
Genes  that  activate  HIF-1˛  system
HIF-1 activation can start by the binding of different proteins
to their receptors on the cell membrane; these proteins may be
enzymes, growth factors, interleukins or other type molecules; Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
that they can be affected by the presence of genetic polymor-
phisms which may be associated with the development of OA.
Yang et al. analyzed the effect of receptor advanced glyca-
tion end products (RAGE) polymorphisms on susceptibility to
xia
tination
F-1 α HIF-1 α
Ub
Ub
Proteasome
Degradation
xia conditions, the speciﬁc proline residues 402 and 564 on
roxylases (PHDs) that leads to the formation of a complex
ubiquitin (Ub) and is subsequently degraded by the
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VEGF
PI3K
AKT
FRAP
PHD
P
P
MAPK
HIF-1α
HIF-1αTranscription
HIF-1α
HIF-1α
HRE
HIF-1β
HIF-1α
VEGF
NOS II/III
NQO1
MMPs
EPO
ET-1
GLUT-1 Glucosetranporter
Mitogen
Erythropoiesis
Matrix
remodeling
Antioxidant
Vasodilation
extravasation
Angiogenesis
O2
Hypoxia
Fig. 4 – HIF-1  activity under hypoxic conditions. Under hypoxic conditions, HIF-1  is stabilized and phosphorylated by
MAPK; once phosphorylated, HIF-1  translocates to the nucleus and binds to HIF-1 subunit to form the [HIF-1/HIF-1]
complex. This complex, through the HRE, binds to speciﬁc DNA sequence 5′TAGCGTGH3′ present in the promoter regions of
several genes for their subsequent activation.and severity of OA in a Han Chinese population. RAGE par-
ticipates in regulating inﬂammation, even in the production
of matrix metalloproteinases (MMPs). MMP-1 degrades carti-
lage, which may result in OA development. They found that
two polymorphisms (rs1800625 and rs2070600)  in RAGE gene
showed a signiﬁcant association between OA patients and
healthy controls (OR = 0.42, p = 0.016, and OR = 2.78, p = 0.047,
respectively).65 In the study performed by Han et al.,26 they
evaluated that the presence of rs2070600 polymorphism in
RAGE gene in interaction with obesity, may determine the sus-
ceptibility of knee OA.
Swellam et al. reported a potential inﬂuence of intereukin-
1 receptor antagonist (IL-1RA) gene polymorphism on knee
OA risk. IL-1 gene is supposed to be involved in the carti-
lage destruction process. In this regard, interleukin-1 receptor
antagonist (IL-1RA) competing with IL-1 for binding to its
receptor may act as an inhibitor of cartilage breakdown. They
conducted a case–control study with knee OA patients, and
concluded that IL-1RN*2 allele represent a signiﬁcant factor
inﬂuencing the severity and course of knee OA (p = 0.002).66
Fernandes et al., analyzed the inﬂuence of pro-
inﬂammatory cytokine IL-6 with severity and functional
status of OA in elderly individuals, and determined that
the rs1800796 polymorphism is a protective factor for the
presence and severity of hip and knee OA in the elderly. The
individuals harboring the C allele have lower prevalence and
severity of OA when compared to individuals without this
polymorphism.35Please cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
Meanwhile, interleukin-16 (IL-16), a pleiotropic cytokine,
plays a fundamental role in inﬂammatory diseases. Liu et al.
determined that, compared with the C/C genotype, the C/Tgenotype increased the risk of primary knee OA in rs4072111
of IL-16 gene (OR = 1.83); however, compared with the T/T
genotype, the T/G genotype decreased the risk of primary
knee OA in rs11556218 polymorphism (OR = 0.37).37 Likewise,
Luo et al. evaluated the same polymorphisms and deter-
mined the same behavior.36 These results suggest that IL-16
gene polymorphisms are associated with the risk of knee
OA.
Finally, there are other genes associated with activation of
HIF-1, such as PIK3R1, AKT2, GSK3B,  IL6,  and it will be neces-
sary to explore their genetic variants and to determine their
participation in the development of OA.
Proteins  that  interact  directly  with  HIF-1˛
The stabilization of HIF-1 in the cytoplasm basically depends
on the hydroxylation at speciﬁc sites within of the ODDD
domain. However, the presence of genetic polymorphisms
could alter the structural properties of the transcripts, and this
may inﬂuence the susceptibility or resistance to diseases, such
as was analyzed by Uchanzka et al. in autoimmune diseases
associated with HLA-B*27 allele.67
In 2003 Tanimoto et al. demonstrated that the substitution
of proline by serine in the 582 (P582S) position, due to the pres-
ence of single nucleotide polymorphism (rs11549465) within
HIF1A gene, enhances its transcriptional activity,56 due to an
alteration in the characteristics and properties of the binding
sites with the target genes.67,68 Recently, our group evaluated Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
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the presence of this polymorphism in samples of patients
with OA, ﬁnding that was associated positively as a protec-
tive factor in cartilage loss (CT genotype OR = 0.2, p = 0.003,
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PHD
bHLH
bHLH
PAS A
PAS A
PAS B
PAS B
ODDD
ODDD
N-TAD
N-TAD
VHL
VHL
NLS
NLS
NLS
NLS
In presence of rs11549465 SNP, proline is changed by serine
No degradation
40
2
56
4
58
2
40
2
56
4
58
2
OH
OH OH
OH OH
TAD-C
TAD-C
Ubiquitination Degradation
Fig. 5 – The presence of rs11549465 polymorphism, generates a change of proline by serine, which confers greater stability
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io the HIF-1 protein due to poor interaction between VHL a
r T allele OR = 0.2, p = 0.004).34 This phenomenon may be
xplained by the fact that the presence of this polymorphism
onfers greater stability to the HIF-1 protein due to poor inter-
ction between VHL and hydroxylation sites within the ODDD
Fig. 5).
Other polymorphism medically important, with increased
ranscriptional activity within HIF1A gene that also was tested
y Tanimoto et al., is Ala588Thr (rs11549467). Similarly, we
valuate this polymorphism in patients with OA, but did not
nd him associated. However, this opens the possibility to be
valuated in other populations in order to better understand
heir inﬂuence in OA.
Additionally, it have been described polymorphisms for
GLN1 (also known as PHD2, prolyl-hydroxylase 2), VHL and
IF1AN (HIF1A inhibitor factor) genes interacting directly with
IF-1,  but not have been evaluated in OA and that may
e of clinical importance in this disease. Some studies in
heumatoid arthritis (RA) demonstrated the expression and
egulation of prolyl hydroxylase domain (PHD) enzymes and
actor-inhibiting HIF-1  (FIH-1), which regulate cellular HIF-
 levels. It is known that RA is characterized by hypoxia
nd the expression of hypoxia-inducible transcription factors
HIFs), which coordinate cellular responses to hypoxia. Muz
t al. conducted this study in RA ﬁbroblast-like synoviocytes,
nd concluded that PHD-2 is the major hydroxylase regu-
ating HIF levels and the expression of angiogenic genes in
rthritic cells. PHD-2 appears to regulate responses relevant to
rthritis via HIF-, highlighting the major importance of this
nzyme in hypoxia- and angiogenesis-dependent inﬂamma-
ory diseases.69 This makes us suppose that the presence of
enetic polymorphisms of these genes may affect the stability
f HIF-1 contributing importantly in the OA disease.
enes  driving  by  HIF-1˛Please cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
A chondrocytes are metabolically active, displaying
ncreased synthesis of type II collagen. In comparison withydroxylation sites within the ODDD.
healthy cartilage, OA articular chondrocytes exhibit increased
in vivo synthesis of collagen prolyl-4-hydroxylase type II, a
pivotal enzyme in collagen triple helix formation.70 Once
stabilized HIF-1 in the cytoplasm, several downstream genes
are expressed in order to restore multiple components of the
extracellular matrix. The presence of genetic polymorphisms
in these genes may alter the function of speciﬁc proteins that
restore joint tissues, promoting the development of OA.
Raine et al. performed an allelic expression analysis of
the OA susceptibility gene COL11A1 in human joint tissues.
By using RNA from OA cartilage of individuals undergo-
ing elective joint replacement for OA of the hip (total
hip replacement, THR) or of the knee (total knee replace-
ment, TKR), they observed a signiﬁcant allelic expression
imbalance (AEI) at rs1676486 (p < 0.0001) with the T-allele cor-
relating with reduced COL11A1 expression. AEI at rs1676486
is a risk factor for lumbar disk herniation, but not for
OA.71
Rodríguez-Fontenla et al. conducted a meta-analysis of
nine GWAS to assess candidate genes for association with
OA, and only 2 of the 199 candidate genes (COL11A1 and
VEGF) were associated with OA in the meta-analysis. Two
polymorphisms in COL11A1 gene (rs4907986 and rs1241164)
showed association with hip OA in the combined analysis
(OR = 1.12, p = 1.29 × 10−5, and OR = 0.82, p = 1.47 × 10−5, respec-
tively); and the rs4908291 with the sex stratiﬁed analysis in
women only (OR = 0.87, p = 1.29 × 10−5). Other polymorphism
in VEGF gene (rs833058) showed association with hip OA in
men  only (OR = 0.85, p = 1.35 × 10−5).72
The oxygen and nutrients supply to articular cartilage is
by diffusion from the synovial ﬂuid. The role of vascular
endothelium growth factor (VEGF) is critical for angiogene-
sis in subchondral bone.8 There are only few studies related
with gene variants of VEGF gene that may contribute to the Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
development and progress of OA.
Sánchez et al. evaluated two polymorphisms of VEGF gene,
−460T/C and +405C/G, in patients with knee OA and compared
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with healthy controls, but did not ﬁnd association.73 Yuan
et al. conducted a meta-analysis to order understand the rela-
tionship between the pathogenesis of OA and the expression
levels of VEGF in multiple disease tissues in these patients.
A total of 11 case–control studies, containing 302 OA patients
and 195 healthy controls, demonstrate that VEGF expression
levels in OA patients are signiﬁcantly higher than healthy con-
trols (standardized mean difference = 1.18, 95% CI: 4.91–9.11,
p < 0.001), and these levels strongly correlate with the patho-
genesis of osteoarthritis.74
One of the mechanisms of cartilage degradation in OA is
enzymatic proteolysis of the extracellular matrix by metallo-
proteinases. MMP-1, produced by chondrocytes and synovial
cells, is a major protease of the MMPs  family.
Barlas et al. evaluated three polymorphisms in the pro-
moter of matrix metalloproteinase-1 (MMP-1), MMP-2 and
MMP-9 genes in patients with knee OA and compared with
ethnically matched control. They found signiﬁcant differences
between the groups regarding the genotype distribution of
MMP-1 polymorphism (p = 0.001). The frequencies of 1G/1G and
1G/2G genotypes were signiﬁcantly higher in the knee OA than
in the controls (p = 0.002, and p = 0.006, respectively). In addi-
tion, 1G allele frequency of MMP-1 gene was higher in the
patients than in the control group (p = 0.0001). The genotype
distributions and allele frequencies of MMP-2 and MMP-9 gene
polymorphisms did not differ between the OA and the control
groups (p > 0.05). These ﬁndings suggest that the −1607 1G/2G
polymorphism (rs1799750) in the MMP-1 gene may contribute
to susceptibility to knee OA.75
Similarly, Lepestos et al. evaluated the rs1799750 poly-
morphism in MMP-1 gene, but they did not ﬁnd signiﬁcant
association in crude analysis; however, after multiple logis-
tic regression analysis, 1G/2G was associated with reduced
odds of knee OA by 75% in males, compared to genotypes
1G/1G + 2G/2G, adjusting for age and BMI  (adjusted OR = 0.25,
p = 0.035).76
Finally, Honsawek et al. analyzed the MMP-3 (rs3025058,
−1612) polymorphism with knee OA patients. The 5A allele
frequency was indicated as 15.5%, and 6A allele was as 84.5%
in OA patients, whereas it was 10–90% in the control group.
Accordingly, the present study has indicated that the −1612
5A/6A polymorphism genotypes of MMP-3 gene promoter do
not play a role in the development of OA.77
These results suggest that the MMPs  family activity is inﬂu-
enced by presence of genetic variants, which would break the
balance between synthesis and degradation of extracellular
matrix, and this condition may contribute to susceptibility of
OA.
Nitric oxide (NO) is essential in the maintenance of vascular
tonus and the presence of endothelial impairment (reduced
vascular relaxation) may suggest a problem regarding the NO
pathway. NO is produced by endothelial NO synthase (eNOS),
and its production can be inﬂuenced by polymorphisms of
the eNOS gene.78 To date, no studies have been done related
with OA and genetic polymorphisms of NOS; however, several
genetic polymorphisms in the eNOS gene are associated withPlease cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
the pathogenesis of RA.
The level of NO is increased in RA patients, and a study
suggested that NO can regulate the balance of Th1/Th2 in 1 6;x  x x(x x):xxx–xxx
autoimmune diseases, and it was a key mediator of apo-
ptosis within rheumatoid arthritis joints. An et al. studied
two polymorphisms of the eNOS gene (rs2070244, T-786C; and
rs1799983, G894T) in patients with RA, and observed that indi-
viduals with the −786CC genotype have an increased risk of
RA.79
Brenol et al. evaluated the T-786C polymorphism in RA
patients comparing with extraarticular manifestations. They
found that the C allele was signiﬁcantly associated (p cor-
rected = 0.032), suggesting the participation of the T-786C
polymorphism of the eNOS gene and RA.80
These results we  make suppose that eNOS gene polymor-
phisms can have an important impact on development of OA;
it will be necessary to explore these genetic variants to cor-
roborate it.
The erythropoietin-mediated bone marrow response to
anemia is under the control of hypoxia-inducible factors
(HIFs), the master regulators of oxygen and iron homeostasis.
The hypoxic characteristics of joint cartilage make that HIF-
1 participates actively allowing transcription of target genes.
Erythropoietin (EPO) gene is expressed after of an increase of
HIF-1 on cytoplasm.81,82 But to date, no scientiﬁc evidence
that supports the possible association between erythropoie-
tin and cartilage loss in OA; and even more,  the presence of
polymorphisms in EPO gene could represents an important
factor associated with risk of OA.
Clinical  relevance  of  PHDs  inhibitors  as
potential  therapeutic  targets  in  OA
To date, HIF-1 inhibitors are classiﬁed by their HIF inhibitory
mechanism, including affecting on HIF-1 protein level, HIF-
1 dimerization, HIF-1 DNA binding, or HIF-1 transcription
of target genes.83 Due to the results described above, the
main objective for achieving a therapeutic effect in the treat-
ment of OA at cartilage level, could stabilize HIF-1 in the
cytoplasm so that it can induce the expression of restora-
tion genes. Naturally, there are genetic polymorphisms that
increase the transcriptional activity of HIF-1 in comparison
with common isoform. At the experimental level, has evalu-
ated the Dimethyloxallyl Glycine (DMOG), a potent inhibitor
of prolyl-hydroxylases.84 The endogenous HIF-1 levels can
be increased by the suppression of PHD activity, either by
reducing the cellular oxygen level or by combining the Fe
(II) competitively. DMOG is a cell permeable, competitive
inhibitor of the PHDs. DMOG is an analog of 2-oxoglutarate,
and in this way it inhibits not only the HIF prolyl but also
asparaginyl hydroxylases. Beside that it is predicted to inhibit
other members of 2-oxoglutarate-dependent dioxygenases.
There are three HIF-prolyl hydroxylases known in mammals,
and they are encoded by separate genes: PHD1, PHD2, and
PHD3. Like all 2-oxoglutarate-dependent dioxygenases, PHDs
require oxygen for hydroxylation, as well as tricarboxylic
acid cycle intermediate, 2-oxoglutarate (-ketoglutarate), iron Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
(Fe2+), and ascorbate as cofactors. When oxygen levels are
low, HIF-1  escapes PHD hydroxylation and recognition by the
VHL.85,86
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Other inhibitors of PHDs with potential beneﬁcial effects
re deferoxamine (DFO) and cobalt chloride (CoCl2), an iron
helator and a competitive inhibitor of iron, respectively; they
re routinely used both in vitro and in vivo to inhibit PHDs activ-
ty by competing for endogenous iron (II). Other iron chelators,
uch as ciclopirox olamine, and competitive inhibitors of
ron, such as Cu2+, Zn2+, and Mn2+, are also used as PHDs
nhibitors.53
Likewise, there are studies showing that HIF-1 and its tar-
et gene VEGF, are critical regulators of angiogenic–osteogenic
oupling.7,87 In addition to chondrocytes, osteoblasts also
xpress HIF-1  and promote skeletal vascularization dur-
ng endochondral bone formation; manipulation of the HIF
ystem via pharmacological or genetic approaches, is an
ttractive strategy for treating hypoxic diseases, including
keletal diseases such as subchondral bone inﬂammation dur-
ng OA.53
onclusion
s worth mentioning that several associations’ studies
etween SNPs and OA disease remain unconﬁrmed or con-
roversial due to bias in patient enrolling criteria differences
n OA affected joint sites, in classiﬁcation and staging mode.
Cartilage destruction in OA mediated by catabolic
nzymes and chondrocyte death, including apoptosis and/or
utophagy, also contribute to the pathogenesis. The studies
howed that the expression of HIF-1 is increased in OA
artilage to mediate the response of chondrocytes to hypoxia;
IF-1 acts as a survival factor by enhancing extracellular
atrix synthesis and inhibiting apoptosis88; HIF-1 serves to
egulate both autophagy and apoptosis and HIF-1 is of pivotal
mportance in cartilage homeostasis.89 Also, it will also be
ecessary to explore other isoforms of HIF, such as HIF-2,
hich it seems to have the opposite effect to HIF-1. The
IF-2 protein acts as a brake on the autophagy-accelerator
unction of HIF-1, and promotes chondrocyte hypertrophy, a
erminal differentiation state characterized by a unique gene
xpression program, including type X collagen and the type II
ollagen-degrading protease MMP-13.9
Although further studies should elucidate the exact mech-
nism of HIF-1 in OA the current evidence induce to consider it
s a promising approach to the treatment of OA. However, the
esults have been reported to indicate that genetic markers
ould contribute to the understanding of the natural history
f this disease.
onﬂict  of  interest
he authors declare no conﬂicts of interest.
cknowledgmentsPlease cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
he authors wish to thank Carlos Aguilar-González for his
aluable support in the design of Figs. 3 and 4. 6;x  x x(x x):xxx–xxx 9
 e  f  e  r  e  n  c  e  s
1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati
M, et al. Years lived with disability (YLDs) for 1160 sequelae of
289  diseases and injuries 1990–2010: a systematic analysis for
the Global Burden of Disease Study 2010. Lancet.
2012;380:2163–96.
2. Fichera C, Pappalardo A, Triolo G, Gallo M, Valentini G,
Bagnato G. Epidemiology and risk factors in osteoarthritis:
literature review data from OASIS study. Reumatismo.
2004;56:169–84.
3. Komatsu M, Kamimura M, Nakamura Y, Mukaiyama K,
Ikegami S, Uchiyama S, et al. Rapid bone destruction in a
patient with knee osteoarthritis. A case report and review of
the literature. Clin Cases Miner Bone Metab. 2014;11:
232–5.
4. Schiphof D, van Middelkoop M, de Klerk BM,  Oei EH, Hofman
A, Koes BW, et al. Crepitus is a ﬁrst indication of
patellofemoral osteoarthritis (and not of tibiofemoral
osteoarthritis). Osteoarthritis Cartilage. 2014;201:631–8.
5. Musumeci G, Aiello FC, Szychlinska MA, Di Rosa M,
Castrogiovanni P, Mobasheri A. Osteoarthritis in the XXIst
century: risk factors and behaviours that inﬂuence disease
onset and progression. Int J Mol Sci. 2015;16(3):
6093–112.
6. Meulenbelt I. Osteoarthritis year 2011 in review: genetics.
Osteoarthritis Cartilage. 2012;20:218–22.
7. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M,
Johnson RS. Hypoxia in cartilage: HIF-1 alpha is essential for
chondrocyte growth arrest and survival. Genes Dev.
2001;15:2865–76.
8. Pfander D, Cramer T, Hypoxia Swoboda B. HIF-1 alpha in
osteoarthritis. Int Orthop. 2005;29(1):6–9.
9. Coimbra IB, Jimenez SA, Hawkins DF, Piera-Velazquez S,
Stokes DG. Hypoxia inducible factor-1 alpha expression in
human normal and osteoarthritic chondrocytes.
Osteoarthritis Cartilage. 2004;12(4):336–45.
0. Stokes DG, Liu G, Coimbra IB, Piera-Velazquez S, Crowl RM,
Jiménez SA. Assessment of the gene expression proﬁle of
differentiated and dedifferentiated human fetal chondrocytes
by microarray analysis. Arthritis Rheum. 2002;46(2):
404–19.
1. Pfander D, Swoboda B, Cramer T. The role of HIF-1alpha in
maintaining cartilage homeostasis and during the
pathogenesis of osteoarthritis. Arthritis Res Ther. 2006;8:104.
Epub 2006 Jan 18.
2. Ströbel S, Loparic M, Wendt D, Schenk A, Candrian C,
Lindberg R, et al. Anabolic and catabolic responses of human
articular chondrocytes to varying oxygen percentages.
Arthritis Res Ther. 2010;12:R34.
3. Grimmer C, Pfander D, Swoboda B, Aingner T, Mueller L,
Henning F, et al. Hypoxia-Inducible Factor 1 is involved in the
prostaglandin metabolism of osteoarthritic cartilage through
up-regulation of microsomal prostaglandin E synthase 1 in
articular chondrocytes. Arthritis Rheum. 2007;56:
4084–94.
4. Distler K. Hypoxia and angiogenesis in rheumatic diseases. Z
Rheumatol. 2003;62 Suppl2:II43–5.
5. Wu L, Huang X, Li L, Huang H, Xu R, Luyten W.  Insights on
biology and pathology of HIF-1/-2, TGF/BMP,
Wnt/-catenin, and NF-(B pathways in osteoarthritis. Curr
Pharm Des. 2012;18(22):3293–312.
6. Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA. Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
meta-analyses: the PRISMA statement. PLOS Med.
2009;6:e1000097.
ARTICLE IN PRESSRBRE-311; No. of Pages 12
 l . 2 0
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
510  r e v b r a s r e u m a t o
7. Guilak F. Biomechanical factors in osteoarthritis. Best Pract
Res Clin Rheumatol. 2011;25:815–23.
8. Lee KM, Chung CY, Sung KH, Lee SY, Won SH, Kim TG, et al.
Risk factors for osteoarthritis and contributing factors to
current arthritic pain in South Korean older adults. Yonsei
Med J. 2015;56:124–31.
9. De Filippis L, Gulli S, Caliri A, Romano C, Munaó F, Trimarchi
G, et al. Epidemiology and risk factors in osteoarthritis:
literature review data from OASIS study. Reumatism.
2004;56:169–84.
0. Fernández M, Rego F, Blanco F. Genetics in osteoarthritis.
Reumatol Clin. 2007;3 Supl 3:S13–8.
1. Chapman K, Valdes AM. Genetic factors in OA pathogenesis.
Bone. 2012;51:258–64.
2. Shi D, Zheng Q, Chen D, Zhu L, Qin A, Fan J, et al. Association
of  single-nucleotide polymorphism in HLA class II/III region
with knee osteoarthritis. Osteoarthritis Cartilage.
2010;18:1454–7.
3. Seal A, Gupta A, Mahalaxmi M, Aykkal R, Singh TR,
Arunachalam V. Tools, resources and databases for SNPs and
indels in sequences: a review. Int J Bioinform Res Appl.
2014;10:264–96.
4. Knez K, Spasic D, Janssen KP, Lammertyn J. Emerging
technologies for hybridization based single nucleotide
polymorphism detection. Analyst. 2014;139:353–70.
5. Urano T, Narusawa K, Hosoi T, Ouchi Y, Nakamura T, Inoue S.
Association of a single nucleotide polymorphism in the
WISP1 gene with spinal osteoarthritis in postmenopausal
Japanese women. J Bone Miner Metab. 2007;25:253–8.
6. Han Z, Liu Q, Sun C, Li Y. The interaction between obesity and
RAGE polymorphisms on the risk of knee osteoarthritis in
Chinese population. Cell Physiol Biochem. 2012;30:
898–904.
7. Zhang R, Yao J, Xu P, Ji B, Voegeli G, Hou W,  et al. Association
between genetic variants of DVWA and osteoarthritis of the
knee and hip: a comprehensive meta-analysis. Int J Clin Exp
Med.  2015;8(6):9430–7.
8. Qing Z, Ye J. Association between ACE polymorphisms and
osteoarthritis susceptibility. Int J Clin Exp Pathol.
2015;8(6):7391–6.
9. Gu J, Rong J, Guan F, Jiang L, Tao S, Guan G, et al. MATN3 gene
polymorphism is associated with osteoarthritis in Chinese
han  population: a community-based case–control study.
Scientiﬁc World J. 2012;2012:656084,
http://dx.doi.org/10.1100/2012/656084.
0. Meulenbelt I, Min J, Bos S, Riyazi N, Houwing J, Slagboom E,
et  al. Identiﬁcation of DIO2 as a new susceptibility locus for
symptomatic osteoarthritis. Hum Mol Genet. 2008;17:
1867–75.
1. Poonpet T, Honsawek S, Tammachote N, Kanitnate S,
Tammachote R. ADAMTS14 gene polymorphism associated
with knee osteoarthritis in Thai women. Genet Mol Res.
2013;12(4):5301–9.
2. Wang L, Guo L, Tian F, Hao R, Yang T. Analysis of single
nucleotide polymorphisms within ADAM12 and risk of knee
osteoarthritis in a Chinese Han population. Biomed Res Int.
2015;2015:518643.
3. Kerna I, Kisand K, Tamm AE, Kumm J, Tamm AO. Two
single-nucleotide polymorphisms in ADAM12 gene are
associated with early and late radiographic knee
osteoarthritis in Estonian population. Arthritis.
2013;2013:878126.
4. Fernández-Torres J, Hernández-Díaz C, Espinosa-Morales R,
Camacho-Galindo J, Galindo-Sevilla Ndel C, López-Macay A,Please cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
et  al. Polymorphic variation of hypoxia inducible factor-1 A
(HIF1A) gene might contribute to the development of knee 1 6;x  x x(x x):xxx–xxx
osteoarthritis: a pilot study. BMC Musculoskelet Disord.
2015;16(1):218, http://dx.doi.org/10.1186/s12891-015-0678-z.
5.  Fernandes MT, Fernandes KB, Marquez AS, Cólus IM, Souza
MF, Santos JP, et al. Association of interleukin-6 gene
polymorphism (rs1800796) with severity and functional
status of osteoarthritis in elderly individuals. Cytokine.
2015;75(2):316–20.
6. Luo SX, Li S, Zhang XH, Zhang JJ, Long GH, Dong GF, et al.
Genetic polymorphisms of interleukin-16 and risk of knee
osteoarthritis. PLoS One. 2015;10(5):e0123442,
http://dx.doi.org/10.1371/journal.pone.0123442.
7. Liu Z, Ma L, Qiu S, Jia T. Genetic polymorphisms of
interleukin-16 are associated with susceptibility to primary
knee osteoarthritis. Int J Clin Exp Med. 2015;8(1):1401–5,
eCollection 2015.
8. Pan F, Tian J, Winzenberg T, Ding C, Jones. Association
between GDF5 rs143383 polymorphism and knee
osteoarthritis: an updated meta-analysis based on 23,995
subjects. BMC Musculoskelet Disord. 2014;15:404,
http://dx.doi.org/10.1186/1471-2474-15-404.
9. Tawonsawatruk T, Changthong T, Pingsuthiwong S, Trachoo
O, Saura T, Wajanavisit W.  A genetic association study
between growth differentiation factor (GDF5) polymorphism
and knee osteoarthritis in Thai population. J Orthopaed Surg.
2011;Res6:2–5.
0. Sophia Fox AJ, Bedi A, Rodeo SA. The basic science of articular
cartilage: structure, composition, and function. Sports Health.
2009;1(6):461–8.
1. Mariani E, Pulsatelli L, Facchini A. Signaling pathways in
cartilage repair. Int J Mol Sci. 2014;15:8667–98.
2. Chen JL, Duan L, Zhu W,  Xiong J, Wang D. Extracellular matrix
production in vitro in cartilage tissue engineering. J Transl
Med. 2014;12:88, http://dx.doi.org/10.1186/1479-5876-12-88.
3. Findlay DM, Atkins GJ. Osteoblast–chondrocyte interactions in
osteoarthritis. Curr Osteoporos Rep. 2014;12:127–34.
4. Iwamoto M, Ohta Y, Larmour C, Enomoto-Iwamoto M. Toward
regeneration of articular cartilage. Birth Defects Res C Embryo
Today. 2013;99:192–202.
5. Maldonado M, Nam J. The role of changes in extracellular
matrix of cartilage in the presence of inﬂammation on the
pathology of osteoarthritis. Biomed Res Int. 2013;2013:284873,
http://dx.doi.org/10.1155/2013/284873.
6. van der Kraan PM. Osteoarthritis year 2012 in review: biology.
Osteoarthritis Cartilage. 2012;20:1447–50.
7. Zhang FJ, Luo W,  Lei GH. Role of HIF-1 and HIF-2 in
osteoarthritis. Joint Bone Spine. 2015;82(3):144–7.
8. Loboda A, Jozkowicz A, Dulak J. HIF-1 and HIF-2 transcription
factors–similar but not identical. Mol  Cells. 2010;29(5):
435–42.
9. Görlach A. Regulation of HIF-1 alpha at the transcriptional
level. Curr Pharm Des. 2009;15:3844–52.
0. Semenza GL. HIF-1: mediator of physiological and
pathophysiological responses to hypoxia. J Appl Physiol.
2000;88:1474–80.
1. Maxwell PH. Hypoxia-inducible factor as a physiological
regulator. Exp Physiol. 2005;90(6):791–7.
2. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL.
Insulin-like growth factor 1 induces hypoxia-inducible factor
1-mediated vascular endothelial growth factor expression,
which is dependent on MAP kinase and phosphatidylinositol
3-kinase signaling in colon cancer cells. J Biol Chem.
2002;277:38205–11.
3. Fan L, Li J, Yu Z, Dang X, Wang K. The hypoxia-inducible
factor pathway, prolyl hydroxylase domain protein inhibitors, Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
and their roles in bone repair and regeneration. Biomed Res
Int. 2014;2014:239356, http://dx.doi.org/10.1155/2014/239356.
ARTICLE IN PRESSRBRE-311; No. of Pages 12
. 2 0 1
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7
8
8
8
8
8r  e v b r a s r e u m a t o l 
4. Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L.
Hyperglycemia regulates hypoxia-inducible factor-1 alpha
protein stability and function. Diabetes. 2004;53(12):
3226–32.
5. Zhou J, Hara K, Inoue M, Hamada S, Yasuda H, Moriyama H,
et  al. Regulation of hypoxia-inducible factor 1 by glucose
availability under hypoxic conditions. Kobe J Med Sci.
2008;53(6):283–96.
6. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K,
Kumazaki T, et al. Hypoxia-inducible factor-1a
polymorphisms associated with enhanced transactivation
capacity, implying clinical signiﬁcance. Carcinogenesis.
2003;24(11):1779–83.
7. Yamada N, Horikawa Y, Oda N, Iizuka K, Shihara N, Kishi S,
et  al. Genetic variation in the Hypoxia-Inducible Factor-1
gene is associated with type 2 diabetes in Japanese. J Clin
Endocrinol Metab. 2005;90:5841–7.
8. Tzouvelekis A, Ntolios P, Karameris A, Koutsopoulos A, Boglou
P,  Koulelidis A, et al. Expression of hypoxia-inducible factor
(HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory
growth factor (ING)-4- axis in sarcoidosis patients. BMC Res
Notes. 2012;5:654, http://dx.doi.org/10.1186/1756-0500-5-654.
9.  Sartori-Cintra AR, Mara CS, Argolo DL, Coimbra IB. Regulation
of  hypoxia-inducible factor-1 (HIF-1) expression by
interleukin-1  (IL-1 ), insulin-like growth factors I (IGF-I) and
II  (IGF-II) in human osteoarthritic chondrocytes. Clinics (São
Paulo). 2012;67:35–40.
0. Konac E, Dogan I, Onen HI, Yurdakul AS, Ozturk C, Varol A,
et  al. Genetic variations in the hypoxia-inducible
factor-1alpha gene and lung cancer. Exp Biol Med.
2009;234:1109–16.
1. Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW,  et al. Genetic
polymorphisms in HIF1A are associated with prostate cancer
risk in a Chinese population. Asian J Androl. 2012;14(6):
864–9.
2. Alidoosti M, Ghaedi M, Soleimani A, Bakhtiyari S, Rezvanfard
M, Golkhu S, et al. Study on the role of environmental
parameters and HIF-1A gene polymorphism in coronary
collateral formation among patients with ischemic heart
disease. Clin Biochem. 2010;44:1421–4.
3. Bahadori B, Uitz E, Mayer A, Harauer J, Dam K,
Truschnig-Wilders M, et al. Polymorphisms of the
hypoxia-inducible factor 1 gene and peripheral artery disease.
Vasc Med. 2010;15:371–4.
4. Nagy G, Kovacs R, Kereszturi E, Somogyi A, Szekely A, Nemeth
N,  et al. Association of hipoxia inducible factor-1 alpha gene
polymorphism with both type 1 and type 2 diabetes in a
Caucasian (Hungarian) sample. BMC Med Genet. 2009;10:79,
http://dx.doi.org/10.1186/1471-2350-10-79.
5. Yang HY, Chuang SY, Fang WH,  Huang GS, Wang CC, Huang
YY, et al. Effect of RAGE polymorphisms on susceptibility to
and severity of osteoarthritis in a Han Chinese population: a
case–control study. Genet Mol Res. 2015;14(3):11362–70,
http://dx.doi.org/10.4238/2015.September.25.3.
6. Swellam M, Mahmoud MS, Samy N, Gamal AA. Potential
inﬂuence of interleukin-1 receptor antagonist gene
polymorphism on knee osteoarthritis risk. Dis Markers.
2010;28(5):299–305, http://dx.doi.org/10.3233/DMA-2010-0708.
7.  Uchanska-Ziegler B, Loll B, Fabian H, Hee CS, Saenger W,
Ziegler A. HLA class I-associated diseases with a suspected
autoimmune etiology: HLA-B27 subtypes as a model system.
Eur J Cell Biol. 2012;91(4):274–86.
8. Hong JM, Kim TH, Chae SC, Koo KH, Lee YJ, Park EK, et al.
Association study of hypoxia inducible factor 1 alpha (HIF-1Please cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
alpha) with osteonecrosis of femoral head in a Korean
population. Osteoarthritis Cartilage. 2007;15(6):688–94. 6;x  x x(x  x):xxx–xxx 11
9. Muz B, Larsen H, Madden L, Kiriakidis S, Paleolog EM. Prolyl
hydroxylase domain enzyme 2 is the major player in
regulating hypoxic responses in rheumatoid arthritis.
Arthritis Rheum. 2012;64(9):2856–67,
http://dx.doi.org/10.1002/art.34479.
0. Grimmer C, Balbus N, Lang U, Aigner T, Cramer T, Müller L,
et  al. Regulation of type II collagen synthesis during
osteoarthritis by prolyl-4-hydroxylases: possible inﬂuence of
low  oxygen levels. Am J Pathol. 2006;169(2):491–502.
1. Raine EV, Dodd AW, Reynard LN, Loughlin J. Allelic expression
analysis of the osteoarthritis susceptibility gene COL11A1 in
human joint tissues. BMC Musculoskelet Disord. 2013;14:85,
http://dx.doi.org/10.1186/1471-2474-14-85.
2. Rodriguez-Fontenla C, Calaza M, Evangelou E, Valdes AM,
Arden N, Blanco FJ, et al. Assessment of osteoarthritis
candidate genes in a meta-analysis of nine genome-wide
association studies. Arthritis Rheumatol. 2014;66(4):
940–9.
3. Sánchez-Enríquez S, Torres-Carrillo NM, Vázquez-Del
Mercado M, Salgado-Goytia L, Rangel-Villalobos H,
Mun˜oz-Valle JF. Increase levels of apo-A1 and apo B are
associated in knee osteoarthritis: lack of association with
VEGF-460T/C and +405C/G polymorphisms. Rheumatol Int.
2008;29(1):63–8.
4. Yuan Q, Sun L, Li JJ, An CH. Elevated VEGF levels contribute to
the pathogenesis of osteoarthritis. BMC Musculoskelet Disord.
2014;15:437, http://dx.doi.org/10.1186/1471-2474-15-437.
5. Barlas IO, Sezgin M, Erdal ME, Sahin G, Ankarali HC, Altintas
ZM, et al. Association of (−1607) 1G/2G polymorphism of
matrix metalloproteinase-1 gene with knee osteoarthritis in
the  Turkish population (knee osteoarthritis and MMPs gene
polymorphisms). Rheumatol Int. 2009;29(4):383–8.
6. Lepetsos P, Pampanos A, Kanavakis E, Tzetis M,  Korres D,
Papavassiliou AG, et al. Association of MMP-1 −1607 1G/2G
(rs1799750) polymorphism with primary knee osteoarthritis
in  the Greek population. J Orthop Res. 2014;32(9):
1155–60.
7. Honsawek S, Malila S, Yuktanandana P, Tanavalee A,
Deepaisarnsakul B, Parvizi J. Association of MMP-3 (-1612
5A/6A) polymorphism with knee osteoarthritis in Thai
population. Rheumatol Int. 2013;33(2):435–9.
8. Cooke GE, Doshi A, Binkley PF. Endothelial nitric oxide
synthase gene: prospects for treatment of heart disease.
Pharmacogenomics. 2007;8(12):1723–34.
9. An JD, Li XY, Yu JB, Zhao Y, Jin ZS. Association between the
eNOS gene polymorphisms and rheumatoid arthritis risk in a
northern Chinese population. Chin Med J (Engl).
2012;125(8):1496–9.
0. Brenol CV, Chies JA, Brenol JC, Monticielo OA, Franciscatto P,
Birriel F, et al. Endothelial nitric oxide synthase T-786C
polymorphism in rheumatoid arthritis: association with
extraarticular manifestations. Clin Rheumatol.
2009;28(2):201–5.
1. Haase VH. Regulation of erythropoiesis by hypoxia-inducible
factors. Blood Rev. 2013;27(1):41–53.
2. Torti L, Teoﬁli L, Capodimonti S, Nuzzolo ER, Iachininoto MG,
Massini G, et al. Hypoxia-inducible factor-1 (Pro-582-Ser)
polymorphism prevents iron deprivation in healthy blood
donors. Blood Transfus. 2013;11(4):553–7.
3. Xia Y, Choi HK, Lee K. Recent advances in hypoxia-inducible
factor (HIF)-1 inhibitors. Eur J Med Chem. 2012;49:24–40.
4. Yuan Q, Bleiziffer O, Boos AM, Sun J, Brandl A, Beier JP, et al.
PHDs inhibitor DMOG promotes the vascularization process
in the AV loop by HIF-1a up-regulation and the preliminary Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
discussion on its kinetics in rat. BMC Biotechnol. 2014;14:112,
http://dx.doi.org/10.1186/s12896-014-0112-x.
ARTICLE IN PRESSRBRE-311; No. of Pages 12
 l . 2 0
8
8
8
8
812  r e v b r a s r e u m a t o
5. Brocato J, Chervona Y, Costa M. Molecular responses to
hypoxia-inducible factor 1 and beyond. Mol Pharmacol.
2014;85(5):651–7.Please cite this article in press as: Fernández-Torres J, et al. Role of Hypoxia
review. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.07.00
6. Smith TG, Talbot NP. Prolyl hydroxylases and therapeutics.
Antioxid Redox Signal. 2010;12(4):431–3.
7. Danis A. Mechanism of bone lengthening by the Ilizarov
technique. Bull Mem Acad R Med Belg. 2001;156(1–2):107–12. 1 6;x  x x(x x):xxx–xxx
8. Koh MY, Powis G. Passing the baton: the HIF switch. Trends
Biochem Sci. 2012;37(9):364–72.
9. Bohensky J, Terkhorn SP, Freeman TA, Adams CS, Garcia JA, Inducible Factor-1  signaling pathway in osteoarthritis: a systematic
8
Shapiro IM, et al. Regulation of autophagy in human and
murine  cartilage: hypoxia-inducible factor 2 suppresses
chondrocyte autophagy. Arthritis Rheum. 2009;60(5):
1406–15.
